Research programme: human monoclonal antibodies - Biogen/MorphoSys
Alternative Names: Human monoclonal antibodies research programme - Biogen/MorphoSysLatest Information Update: 01 Aug 2024
At a glance
- Originator Biogen Idec; MorphoSys
- Class Monoclonal antibodies
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 29 Jun 2005 Discontinued - Preclinical for Undefined in Germany (unspecified route)
- 29 Jun 2005 Discontinued - Preclinical for Undefined in USA (unspecified route)
- 30 Sep 2004 The research agreement between Biogen Idec and MorphoSys has successfully concluded